| Vraylar (cariprazine) / Mitsubishi Tanabe, Recordati, Gedeon Richter, AbbVie |
2020-005726-29: An open label signal detection study to evaluate the effects of cariprazine on cognitive functioning in patients with schizophrenia in need of adjustment of oral antipsychotic treatment |
|
|
| Not yet recruiting | 4 | 20 | Europe | Capsule, hard, Reagila | Medical University Innsbruck, Gedeon Richter Plc. | Schizophrenia, Schizophrenia, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
2021-001268-58: Investigation of effects of cariprazine in patients with mitochondrial schizophrenia A cariprazine hatásának vizsgálata mitochondriális dysfunkcióval asszociált schizophreniában |
|
|
| Not yet recruiting | 4 | 10 | Europe | Reagila, Capsule, Reagila | Semmelweis University, STIA-POC-2020, Semmelweis University, STIA-POC-2020, Gedeon Richter | Mitochondrial disease associated schizophrenia Mitochondrialis betegséghez társuló schizophrenia, schizophrenia associating with mitochondrial disease schizophrenia, amely mitochondrialis betegséghez társul, Psychiatry and Psychology [F] - Behavioral Disciplines and Activities [F04] | | | | |
NCT04843423: Adjunct Treatment With Cariprazine for Adults With Attention-deficit/Hyperactivity Disorder |
|
|
| Recruiting | 4 | 15 | Canada | Cariprazine | Dr. Martin A. Katzman | Attention Deficit Hyperactivity Disorder | 12/22 | 04/23 | | |
NCT05384483: Cariprazine Versus Placebo for Social Anxiety Disorder |
|
|
| Not yet recruiting | 4 | 40 | US | Cariprazine, Vraylar®, Placebo | The Medical Research Network, AbbVie | Social Anxiety Disorder | 10/23 | 11/23 | | |
DUAG9, NCT05913947: Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression |
|
|
| Recruiting | 4 | 122 | Europe | Lithium, Litarex, ATC; N05AN01, Cariprazine, Reagila, ATC: N05AX15 | Aalborg University Hospital, Mental Health Center, Glostrup, Mental Health Center North Zealand, Mental Health Department Odense, University Clinic, Psychiatric Center Copenhagen, Rigshospitalet | Depression, Bipolar | 09/24 | 09/24 | | |
| Not yet recruiting | 4 | 2726 | Canada, US | Cariprazine, Vraylar, Aripiprazole/Escitalopram combination, Abilify/ Lexapro, Quetiapine, Seroquel, Lurasidone, Latuda | Massachusetts General Hospital, Patient-Centered Outcomes Research Institute | Bipolar I Disorder, Depression | 02/30 | 02/30 | | |
NCT05060549: Dopamine D3 Receptor Occupancy in Bipolar Depression |
|
|
| Not yet recruiting | 4 | 8 | US | Cariprazine, Vraylar | New York State Psychiatric Institute | Bipolar Depression | 03/25 | 03/25 | | |
NCT05741502: An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine |
|
|
| Recruiting | 4 | 60 | US | Clozapine, Antipsychotics,Other (non-Clozapine), Including Olanzapine, Risperidone, Paliperidone, Quetiapine, Aripiprazole, Ziprasidone, Lurasidone, Cariprazine, and all Typical antipsychotics | Ohio State University | Treatment-resistant Schizophrenia | 03/26 | 06/26 | | |
NCT05933538: Effectiveness of Cariprazine Monotherapy for Treatment of Major Depressive Disorder |
|
|
| Not yet recruiting | 4 | 110 | NA | Cariprazine, Treatment as usual | Sultan Qaboos University | Depressive Disorder, Major | 08/30 | 12/30 | | |
